Provision of comprehensive Care and Treatment Programs by Local Indigenous Entities in The United Republic of Tanzania Under The President’s Emergency Plan for AIDS Relief (PEPFAR) | Apply Online

Frequently Asked Questions (FAQs)

1) What is the title of this funding opportunity?

The opportunity is titled "Provision of comprehensive Care and Treatment Programs by Local Indigenous Entities in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)."

2) Which U.S. government agency is administering this grant action?

This is a U.S. government public health grant action administered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).

3) What larger initiative is this opportunity connected to?

This opportunity is tied to PEPFAR (the President's Emergency Plan for AIDS Relief), the U.S. initiative supporting HIV prevention, care, and treatment services globally.

4) What is the geographic focus of the program?

The geographic focus is the United Republic of Tanzania.

5) What is the main purpose of this opportunity?

The opportunity is centered on sustaining or advancing comprehensive HIV care and treatment programming through local, indigenous organizations, with an emphasis on in-country leadership and implementation capacity.

6) What type of award mechanism is being used?

The award mechanism is a cooperative agreement.

7) What does "cooperative agreement" imply for how the CDC will work with the recipient?

Based on the description provided, a cooperative agreement typically means CDC expects substantial involvement beyond issuing funds, often including close collaboration on technical direction, monitoring, reporting, and alignment with PEPFAR strategies and targets.

8) What activity area does this opportunity fall under?

The activity area is Health.

9) What is the CFDA (assistance listing) number for this opportunity?

The CFDA number listed is 93.067, associated with CDC global HIV/AIDS assistance.

10) What is the opportunity category and what does it suggest?

The opportunity category is "continuation," which indicates it is likely intended to extend or continue an existing program rather than initiate a completely new effort from scratch.

11) Who is eligible to apply?

Eligibility is listed as "Others," with a note that additional eligibility clarification exists in a separate field in the full announcement text. From the title and framing provided here, the opportunity indicates an intent to prioritize local Tanzanian entities ("local indigenous entities") as implementers.

12) Are local Tanzanian organizations specifically emphasized?

Yes. The opportunity description signals a focus on "local indigenous entities" in Tanzania, consistent with an emphasis on country ownership and sustainable local capacity.

13) What kinds of HIV program activities are implied by "comprehensive care and treatment" in this context?

Based on the standard PEPFAR care and treatment framing described, comprehensive programming would generally encompass HIV clinical care and antiretroviral therapy (ART) services, patient retention and adherence support, and the systems needed to keep treatment programs functioning effectively.

14) Does the scope include support for ART and clinical monitoring?

Yes. The description indicates comprehensive HIV clinical care and ART services, along with routine clinical monitoring as part of comprehensive programming.

15) What patient support components are commonly part of these programs, based on the information provided?

Programs commonly include patient retention and adherence support and patient-centered supports aimed at reducing loss to follow-up.

16) Does the described scope mention linkages to care from HIV testing?

Yes. The described comprehensive approach commonly includes HIV testing linkages to care.

17) Is rapid initiation of ART included in the described framing?

The description notes that comprehensive programs commonly include rapid initiation of ART when indicated under national guidelines.

18) Are opportunistic infections and co-morbidities addressed in this opportunity's described scope?

Yes. The scope described commonly includes management of opportunistic infections and co-morbidities.

19) Is tuberculosis (TB) mentioned as part of the typical service package?

Yes. The description notes TB screening and referral or integration where applicable as a common component of comprehensive care and treatment programs in PEPFAR contexts.

20) Are pharmacy, supply chain, or laboratory systems included in the described program scope?

Yes. The description includes pharmacy and supply chain support and laboratory systems strengthening as commonly included components.

21) Does the opportunity imply differentiated service delivery approaches?

Yes. The description references differentiated service delivery approaches to keep patients stable and retained in care.

22) What data, monitoring, or reporting elements are implied?

The description indicates programs usually incorporate data systems for case monitoring and reporting, along with monitoring and reporting expectations consistent with a cooperative agreement and PEPFAR alignment.

23) Are quality improvement and workforce development activities part of the described approach?

Yes. The description mentions quality improvement activities and workforce training and mentoring for clinicians and lay cadres.

24) What is the funding opportunity number?

The funding opportunity number is CDC RFA GH13 132203CONT16.

25) When was the opportunity posted and created?

The posting and creation dates are January 27, 2016.

26) What is the application closing date?

The original and current closing dates are both March 29, 2016.

27) What does it mean that the closing date is in 2016?

Based on the details provided, this was a time-limited continuation announcement with a defined submission window that closed on March 29, 2016.

28) Is there a maximum award amount (award ceiling) specified?

The "Award Ceiling" is listed as 0. As described in the summary, this typically indicates that a maximum award amount was not specified in the summarized listing, rather than indicating that no funding was available.

29) How many awards were expected to be made?

The "Expected Awards" field is blank in the excerpt provided, so the number of anticipated recipients cannot be confirmed from this summary alone.

30) Is this opportunity focused on starting new programs or continuing existing ones?

It is categorized as a continuation opportunity, indicating it is intended to maintain or extend ongoing service delivery platforms and preserve gains in treatment coverage and continuity of patient care.

31) What role does "country ownership" play in the way this opportunity is framed?

The framing emphasizes implementation by local Tanzanian entities, aligning with PEPFAR's push toward country ownership and strengthening sustainable local capacity to manage and deliver HIV services.